PHYT VS HHLA Stock Comparison

PerformanceProfitVolatilityTechnicals
PerformanceProfitVolatilityTechnicals

Performance

PHYT
100/100

PHYT returned 7.28% in the last 12 months. Based on SPY's performance of 1.09%, its performance is above average giving it a score of 100 of 100.

HHLA
100/100

HHLA returned 6.60% in the last 12 months. Based on SPY's performance of -0.25%, its performance is above average giving it a score of 100 of 100.

Profit

PHYT
63/100

Out of the last 9 quarters, PHYT has had 7 profitable quarters and has increased their profits year over year on 2 of them.

HHLA
54/100

Out of the last 11 quarters, HHLA has had 7 profitable quarters and has increased their profits year over year on 3 of them.

Volatility

PHYT
33/100

PHYT has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

HHLA
20/100

HHLA has had a lower than average amount of volatility over the last 12 months giving it a score of 20 of 100.

Technicals

PHYT

"Technicals" not found for PHYT

HHLA
64/100

HHLA receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

All score calculations are broken down here to help you make more informed investing decisions

Pyrophyte Acquisition Corp. Summary

New York Stock Exchange / PHYT
Financial Services
Shell Companies
Pyrophyte Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets in the energy transition industries. The company was incorporated in 2021 and is based in Houston, Texas.

HH&L Acquisition Co. Summary

New York Stock Exchange / HHLA
Financial Services
Shell Companies
HH&L Acquisition Co. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on healthcare or healthcare-related companies in Asian markets. The company was incorporated in 2020 and is based in Central, Hong Kong.